A Phase III Study of Abatacept in Japanese Subjects With Rheumatoid Arthritis

Clinical trial NCT00484289 · COMPLETED

Trial details

NCT number: NCT00484289
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2006-12-01
Primary completion: 2010-12-01
Enrollment: 217

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.